Vimarsana
Biggest News Aggregation in the World

Bernhard Lampert News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bernhard Lampert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bernhard Lampert Today - Breaking & Trending Today

Swiss Firm, Five Bankers Charged in U.S. Tax Avoidance Scheme - Vimarsana News

Swiss Firm, Five Bankers Charged in U.S. Tax Avoidance Scheme

(Bloomberg) -- A Swiss firm and five foreign bankers were charged in the U.S. with tax fraud conspiracy, with prosecutors alleging they helped three American taxpayers hide $60 million in assets by moving the money to other secretive jurisdictions.

Indictment Unsealed Against Six Individuals and Foreign Financial Service Firm for Tax Evasion Conspiracy - Vimarsana News

Indictment Unsealed Against Six Individuals and Foreign Financial Service Firm for Tax Evasion Conspiracy

An indictment was unsealed today in New York, New York, that charges offshore financial service executives and a Swiss financial services company with conspiracy to defraud the IRS by...

US indicts 6 foreign nationals, Swiss firm over USD 60 mln - Vimarsana News

US indicts 6 foreign nationals, Swiss firm over USD 60 mln

The US has indicted six foreign nationals and a Swiss company on charges of a conspiracy to defraud the Internal Revenue Service (IRS) by concealing assets and

Swiss firm, 6 foreigners charged with tax fraud, concealed assets worth $60mn: US DoJ - Vimarsana News

Swiss firm, 6 foreigners charged with tax fraud, concealed assets worth $60mn: US DoJ

The US Justice Department (DoJ) on Tuesday charged six foreign nationals and a Swiss company with conspiracy to conceal assets and income worth $60 million

Celcuity Reports Preliminary Data from Phase 1b Trial of Gedatolisib plus Ibrance® and Endocrine The - Vimarsana News

Celcuity Reports Preliminary Data from Phase 1b Trial of Gedatolisib plus Ibrance® and Endocrine The

Search jobs 08-Apr-2021 Celcuity Reports Preliminary Data from Phase 1b Trial of Gedatolisib plus Ibrance® and Endocrine Therapy for Patients with ER+/HER2- Metastatic Breast Cancer and Provides Corporate Update Preliminary Phase 1b Data - Gedatolisib showed a potentially differentiated safety and tolerability profile - Corporate Update - Proceeds from first $15 million tranche increase cash-on-hand to $44 million - - Drug development capabilities and team broadened and expanded - - Conference call and webcast scheduled for today, April 8 at 5 p...